A double-blind, randomized controlled, acute feeding equivalence trial of small, catalytic doses of fructose and allulose on postprandial blood glucose metabolism in healthy participants: The fructose and allulose catalytic effects (FACE) trial

Nutrients

Volumn 10, Issue 6, 2018, Pages

  Braunstein, Catherine R ^a,b   Noronha, Jarvis C ^a,b   Glenn, Andrea J ^a,b   Viguiliouk, Effie ^a,b   Noseworthy, Rebecca ^b   Khan, Tauseef A ^a,b   Au Yeung, Fei ^a,b   Mejia, Sonia Blanco ^a,b   Wolever, Thomas M S ^a,b,c,d   Josse, Robert G ^a,c,d   Kendall, Cyril W C ^a,b,e   Sievenpiper, John L ^a,b,c,d  

^a Toronto 3D Knowledge Synthesis and Clinical Trials Unit   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Catalytic effects; D allulose; D fructose; D psicose; Postprandial blood glucose regulation

Indexed keywords

FRUCTOSE; GLUCOSE; INSULIN; PSICOSE; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BODY MASS; CATALYTIC EFFICIENCY; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; FAINTNESS; FEEDING; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MAXIMUM CONCENTRATION; METABOLIC REGULATION; NAUSEA; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; ADMINISTRATION AND DOSAGE; BEVERAGE; BLOOD; CATALYSIS; CROSSOVER PROCEDURE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; METABOLISM; MIDDLE AGED; ONTARIO; ORAL DRUG ADMINISTRATION; POSTPRANDIAL STATE; SUGAR INTAKE; TIME FACTOR; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; AGED; BEVERAGES; BIOMARKERS; BLOOD GLUCOSE; CATALYSIS; CROSS-OVER STUDIES; DIETARY SUGARS; DOUBLE-BLIND METHOD; FEMALE; FRUCTOSE; GLUCOSE TOLERANCE TEST; HEALTHY VOLUNTEERS; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; ONTARIO; POSTPRANDIAL PERIOD; TIME FACTORS; YOUNG ADULT;

EID: 85048494077     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu10060750     Document Type: Article

References (50)

1. World Health Organization. Sugar Intake for Adults and Children; WHO: Geneva, Switzerland, 2015; p. 49.
2. U.S. Department of Health and Human Services; U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans; U.S. Government Printing Office: Washington, DC, USA, 2015.
3. Public Health England. Sugar Reduction: Achieving the 20% A Technical Report Outlining Progress to Date, Guidelines for Industry, 2015 Baseline Levels in Key Foods and Next Steps; Wellington House: London, UK, 2017.
4. Sievenpiper, J.L. Fructose: Back to the future? Am. J. Clin. Nutr. 2017. [CrossRef] [PubMed]
5. DiNicolantonio, J.J.; O’Keefe, J.H.; Lucan, S.C. Added fructose: A principal driver of type 2 diabetes mellitus and its consequences. Mayo Clin. Proc. 2015, 90, 372–381. [CrossRef] [PubMed]
6. Lustig, R.H. Sickeningly Sweet: Does Sugar Cause Type 2 Diabetes? Yes. Can. J. Diabetes 2016, 40, 282–286. [CrossRef] [PubMed]
7. Taubes, G. The Case Against Sugar; Alfred A Knopf Canada, Random House of Canada, a Division of Penguin Random House of Canada Limited: Toronto, ON, Canada, 2016.
8. Sievenpiper, J.L.; de Souza, R.J.; Mirrahimi, A.; Yu, M.E.; Carleton, A.J.; Beyene, J.; Chiavaroli, L.; Di Buono, M.; Jenkins, A.L.; Leiter, L.A.; et al. Effect of fructose on body weight in controlled feeding trials: A systematic review and meta-analysis. Ann. Intern Med. 2012, 156, 291–304. [CrossRef] [PubMed]
9. Chiavaroli, L.; de Souza, R.J.; Ha, V.; Cozma, A.I.; Mirrahimi, A.; Wang, D.D.; Yu, M.; Carleton, A.J.; Di Buono, M.; Jenkins, A.L.; et al. Effect of Fructose on Established Lipid Targets: A Systematic Review and Meta-Analysis of Controlled Feeding Trials. J. Am. Heart Assoc. 2015, 4, e001700. [CrossRef] [PubMed]
10. Wang, D.D.; de Souza, R.J.; Chiavaroli, L.; Ha, V.; Cozma, A.I.; Mirrahimi, A.; Yu, M.E.; Carleton, A.J.; DiBuono, M.; Jenkins, A.L.; et al. Effect of Fructose on Uric Acid: A Meta-Analysis of Controlled Feeding Trials. J. Nutr. 2012, 142, 916–923. [CrossRef] [PubMed]
11. Wang, D.D.; de Souza, R.J.; Cozma, A.I.; Chiavaroli, L.; Ha, V.; Mirrahimi, A.; Carleton, A.J.; Di Buono, M.; Jenkins, A.L.; Leiter, L.A.; et al. Effect of fructose on postprandial triglycerides: A systematic review and meta-analysis of controlled feeding trials. Atherosclerosis 2014, 232, 125–133. [CrossRef] [PubMed]
12. Chiu, S.; Sievenpiper, J.L.; de Souza, R.J.; Cozma, A.I.; Mirrahimi, A.; Carleton, A.J.; Ha, V.; Di Buono, M.; Jenkins, A.L.; Leiter, L.A.; et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of controlled feeding trials. Eur. J. Clin. Nutr. 2014, 68, 416–423. [CrossRef] [PubMed]
13. Sievenpiper, J.L.; Tappy, L.; Brouns, F. Fructose as a Driver of Diabetes: An Incomplete View of the Evidence. Mayo Clin. Proc. 2015, 90, 984–988. [CrossRef] [PubMed]
14. Sievenpiper, J.L. Sickeningly Sweet: Does Sugar Cause Chronic Disease? No. Can. J. Diabetes 2016, 40, 287–295. [CrossRef] [PubMed]
15. Livesey, G.; Taylor, R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: Meta-analyses and meta-regression models of intervention studies. Am. J. Clin. Nutr. 2008, 88, 1419–1437. [PubMed]
16. Cozma, A.I.; Sievenpiper, J.L.; de Souza, R.J.; Chiavaroli, L.; Ha, V.; Wang, D.D.; Mirrahimi, A.; Yu, M.E.; Carleton, A.J.; Di Buono, M.; et al. Effect of fructose on glycemic control in diabetes: A systematic review and meta-analysis of controlled feeding trials. Diabetes Care 2012, 35, 1611–1620. [CrossRef] [PubMed]
17. Sievenpiper, J.L.; Chiavaroli, L.; de Souza, R.J.; Mirrahimi, A.; Cozma, A.I.; Ha, V.; Wang, D.D.; Yu, M.E.; Carleton, A.J.; Beyene, J.; et al. ‘Catalytic’ doses of fructose may benefit glycaemic control without harming cardiometabolic risk factors: A small meta-analysis of randomised controlled feeding trials. Br. J. Nutr. 2012, 108, 418–423. [CrossRef] [PubMed]
18. Sievenpiper, J.L.; de Souza, R.J.; Cozma, A.I.; Chiavaroli, L.; Ha, V.; Mirrahimi, A. Fructose vs. glucose and metabolism: Do the metabolic differences matter? Curr. Opin. Lipidol. 2014, 25, 8–19. [CrossRef] [PubMed]
19. Hayashi, N.I.T.; Yamada, T.; Okuma, K.; Takehara, I.; Yamamoto, T.; Yamada, K.; Tokuda, M. Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects. Biosci. Biotechnol. Biochem. 2010, 74, 510–519. [CrossRef] [PubMed]
20. Iida, T.; Kishimoto, Y.; Yoshikawa, Y.; Hayashi, N.; Okuma, K.; Tohi, M.; Yagi, K.; Matsuo, T.; Izumori, K. Acute D-Psicose Administration Decreases the Glycemic Responses to an Oral Maltodextrin Tolerance Test in Normal Adults. J. Nutr. Sci. Vitaminol. 2008, 54, 511–514. [CrossRef] [PubMed]
21. Moore, M.C.; Mann, S.L.; Davis, S.N. Acute fructose administration decreases the glycemic response to an oral glucose tolerance test in normal adults. J. Clin. Endocrinol. Metab. 2000, 85, 4515–4519. [CrossRef] [PubMed]
22. Moore, M.C.; Mann, S.L.; Cherrington, A.D. Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes. Diabetes Care 2001, 24, 1882–1887. [CrossRef] [PubMed]
23. Heacock, P.M.; Wolf, B.W. Fructose prefeeding reduces the glycemic response to a high-glycemic index, starchy food in humans. J. Nutr. 2002, 132, 2601–2604. [CrossRef] [PubMed]
24. Iida, T.; Hayashi, N.; Yamada, T.; Yoshikawa, Y.; Miyazato, S.; Kishimoto, Y.; Okuma, K.; Tokuda, M.; Izumori, K. Failure of D-psicose absorbed in the small intestine to metabolize into energy and its low large intestinal fermentability in humans. Metab. Clin. Exp. 2010, 59, 206–214. [CrossRef] [PubMed]
25. Goldenberg, R.; Punthakee, Z. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada: Definition, classification, and diagnosis of diabetes, prediabetes and metabolic syndrome. Can. J. Diabetes 2013, 37, S8–S11. [CrossRef] [PubMed]
26. Urbaniak, G.C.; Plous, S. Research Randomizer (Version 4.0). Available online: http://www.randomizer.org/(accessed on 12 February 2018).
27. Sievenpiper, J.L.; Jenkins, D.J.; Josse, R.G.; Vuksan, V. Dilution of the 75-g oral glucose tolerance test improves overall tolerability but not reproducibility in subjects with different body compositions. Diabetes Res. Clin. Pract. 2001, 51, 87–95. [CrossRef]
28. Group, W.S. Diabetes Mellitus: Report of a WHO Study Group; WHO: Geneva, Switzerland, 1985; p. 99.
29. Schmidt, F.H. Enzymatic determination of glucose and fructose simultaneously. Klinische Wochensch. 1961, 39, 1244–1247. [CrossRef]
30. Peterson, J.I.; Young, D.S. Evaluation of the hexokinase-glucose-6-phosphate dehydrogenase method of determination of glucose in urine. Anal. Biochem. 1968, 23, 301–316. [CrossRef]
31. Liverey, J.H. Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma. Clin. Biochem. 1980, 13, 151–155. [CrossRef]
32. Wolever, T.M.S.; Jenkins, A.L.; Josse, R.G. The glycemic index: Methodology and clinical implications. Am. J. Clin. Nutr. 1991, 54, 846–854. [CrossRef] [PubMed]
33. Matsuda, M. Insulin sensitivity indicies obtained from oral glucose tolerance testing: Comparison witht he euglycemic clamp. Diabetes Care 1999, 22, 1462–1470. [CrossRef] [PubMed]
34. Phillips, D.I.; Hales, C.N.; Osmond, C. Understanding oral glucose tolerance: Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet. Metab. 1995, 12, 931. [CrossRef]
35. Health Canada. Draft Guidance Document on Food Health Claims Related to the Reduction in Post-Prandial Glycaemic Response Bureau of Nutritional Sciences; Bureau of Nutritional Sciences, Food Directorate, Health Products and Food Branch, 2013; p. 12.
36. Williams, J.D. A Multiple Regression Approach to Multiple Comparisons for Comparing Several Treatments with a Control. J. Exp. Educ. 1971, 39, 93–96. [CrossRef]
37. Detry, M.A.; Ma, Y. Analyzing Repeated Measurements Using Mixed Models. JAMA 2016, 315, 407–408. [CrossRef] [PubMed]
38. Schulz, K.F.; Altman, D.G.; Moher, D.; Group, C. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340, c332. [CrossRef] [PubMed]
39. Wolever, T.M.S. The Glycemic Index: A Physiological Classification of Dietary Carbohydrate; Biddles Ltd.: King’s Lynn, UK, 2006.
40. Wolever, T.M.; Chiasson, J.L.; Csima, A.; Hunt, J.A.; Palmason, C.; Ross, S.A.; Ryan, E.A. Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose. Diabetes Care 1998, 21, 336–340. [CrossRef] [PubMed]
41. Wolever, T.M.; Chiasson, J.L.; Hunt, J.A.; Palmason, C.; Ross, S.A.; Ryan, E.A. Similarity of relative glycaemic but not relative insulinaemic responses in normal, IGT and diabetic subjects. Nutr. Res. 1998, 18, 1667–1676. [CrossRef]
42. Guyton, A.C. Textbook of Medical Physiology, 11th ed.; Elsevier Inc.: Philadelphia, PA, USA, 2006.
43. Triplitt, C.L. Examining the mechanisms of glucose regulation. Am. J. Manag. Care 2012, 18, S4–S10. [PubMed]
44. Colagiuri, S.; Sandbaek, A.; Carstensen, B.; Christensen, J.; Glumer, C.; Lauritzen, T.; Borch-Johnsen, K. Comparability of venous and capillary glucose measurements in blood. Diabetes Med. 2003, 20, 953–956. [CrossRef]
45. Haeckel, R.; Brinck, U.; Colic, D.; Janka, H.U.; Puntmann, I.; Schneider, J.; Viebrock, C. Comparability of blood glucose concentrations measured in different sample systems for detecting glucose intolerance. Clin. Chem. 2002, 48, 936–939. [PubMed]
46. Venn, B.S.; Williams, S.M.; Mann, J.I. Comparison of postprandial glycaemia in Asians and Caucasians. Diabetes Med. 2010, 27, 1205–1208. [CrossRef]
47. Kataoka, M.; Venn, B.J.; Williams, S.M.; Te Morenga, L.A.; Heemels, I.M.; Mann, J.I. Glycaemic responses to glucose and rice in people of Chinese and European ethnicity. Diabetes Med. 2012, 30. [CrossRef] [PubMed]
48. Murad, M.H.; Asi, N.; Alsawas, M.; Alahdab, F. New evidence pyramid. Evid. Based Med. 2016, 21, 125–127. [CrossRef] [PubMed]
49. Wolever, T.M.; Vorster, H.H.; Bjorck, I.; Brand-Miller, J.; Brighenti, F.; Mann, J.I.; Ramdath, D.D.; Granfeldt, Y.; Holt, S.; Perry, T.L.; et al. Determination of the glycaemic index of foods: Interlaboratory study. Eur. J. Clin. Nutr. 2003, 57, 475–482. [CrossRef] [PubMed]
50. International Standards Organisation. Food Products—Determination of the Glycaemic Index (GI) and Recommendation for Food Classification; ISO 26642–2010; International Standards Organisation: Geneva, Switzerland, 2010.